Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin and mitotane treatment led to hair re-growth in 62% of dogs with Alopecia X, but this was not always linked to normal hormone levels.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

Deslorelin may help intact male dogs regrow hair from alopecia X, with a 75% success rate and no side effects.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Hormones significantly influence hair growth, with conditions like hirsutism and patterned hair loss linked to hormone levels; more research is needed for full understanding.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Adrenal disorders can cause lasting brain and behavior issues in children.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Men who start puberty later may have lower sperm quality and different hormone levels in adulthood.

Androgens can both increase body hair and cause scalp hair loss.

Current research explores hair growth drugs, while future research aims for personalized treatments.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Testosterone is key for male sexual function, and treating hormone imbalances can improve sexual issues.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Pregnant women with PCOS have higher levels of Neurokinin B in the placenta, especially with female babies.

Most women lack knowledge about androgens and their excess symptoms.

Many women who have used performance-enhancing drugs in Finland show high rates of mental health and substance use issues, and most have normal red blood cell counts.

The removed ovarian tumor was a rare type of blood vessel tumor that improved the patient's symptoms and hormone levels after surgery.

Extracellular vesicles may effectively treat hair loss with minimal side effects.

Endocrine disruptors may cause early hair loss.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.